• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제23권4호
• /
• pp.397-404
• /
• 2020

Purpose: Synbiotics can alleviate some intestinal pathologies or prevent trigger mechanisms for some diseases such as celiac disease (CD). If patients with high levels of anti-tissue transglutaminase (anti-tTG) immunoglobulin A (IgA) antibodies have normal duodenal histology, they are followed as potential CD patients. The aim of this study was to investigate the effect of synbiotic use on the blood levels of anti-tTG antibodies in children. Methods: Eighty-two patients with high anti-tTG levels were included in this study. Patients were randomly divided into two groups. The synbiotic group was treated with a daily dose of a synbiotic including multi-strain probiotics for 20 days. The control group was not administered any medication. Anti-tTG values at baseline and repeat measurements and the percentage change in anti-tTG levels between groups were compared. Results: The anti-tTG level at baseline was 36 U/mL (interquartile range [IQR], 26.4-68 U/mL) in the synbiotic group, and it decreased significantly to 13 U/mL (IQR, 6.5-27.5 U/mL) after 20 days (p<0.05). The anti-tTG level at baseline was 46 U/mL (IQR, 31-89 U/mL) in the control group, which also decreased significantly to 23 U/mL (IQR, 7-41 U/mL) after 20 days (p<0.05). Anti-tTG levels exhibited 73% and 56% decreases in the synbiotic and control groups, respectively (p<0.05). Conclusion: It may be speculated that a synbiotic supplementation can contribute to decreasing anti-tTG levels in children with potential CD.

• 한국환경농학회지
• /
• 제23권1호
• /
• pp.15-21
• /
• 2004

우리나라 중부지역에서 1998년 $3{\sim}5$월에 과수원 토양 164지점(경기 48, 강원 36, 충북 36, 충남 44지점)을 대상으로 표토($0{\sim}20\;cm$)와 심토($20{\sim}40\;cm$)로 나누어 채취하여 토양내 중금속함량과 분포특성, 총함량에 대한 침출액별 가용성 함량비율 및 토양 이화학성과의 관계를 비교 검토한 결과는 다음과 같다. 과수원 토양중 0.1N-HCl 침출성 평균함량은 Cd 0.080, Cu 4.23, Fb 3.42 mg/ks 1N-HCl 침출성 As 평균함량은 0.44 mg/kg, 중금속 총함량은 Zn 78.9, Ni 16.09 및 Hg 0.052 mg/kg 이었다. 과수원 토양내 중금속 평균함량은 우리나라 토양환경보전법의 토양오염 우려기준(Cd 1.5, Cu 50, Pb 100, Zn 300, Ni 40, Hg 4 mg/kg)과 비교하여 $1/2.5{\sim}1/76.9$ 수준으로 안전하였다. 토양의 중금속 총함량에 대한 침출액별 가용성 함량비율은 Cd $5.4{\sim}9.2$, Cu $27.9{\sim}47.8$, Pb $12.6{\sim}21.8$, Zn $15.8{\sim}20.3$, Ni $5.3{\sim}6.3$, Cr $0.7{\sim}3.6%$ 이었고, 특히 0.05 M-EDTA 침출성 Cu 및 Pb의 침출비율이 상대적으로 높게 나타났다. 토양내 Cd, Pb 및 Ni의 총함량은 모래함량과 부의상관, 미사와 점토함량과는 정의 상관을 보였다. 토양의 중금속 총함량에 대한 침출액별 가용성 함량비율은 점토함량과는 부의 상관을 보였으며, Zn과 Ni의 함량비율은 토양 pH값, 유기물 및 유효인산 함량과 정의 상관을 보였다. 이상의 결과에서 볼 때 과수원 토양의 중금속 함량은 토양환경보전법의 토양오염기준보다 매우 낮아 안전하였으나 영농활동에 의한 영향으로 볼 수 있는 농도수준이 검출된 일부 토양에서 조사되었다. 따라서 최근의 친환경농업 측면으로 볼 때 영농형태별 중금속의 분포 및 농업자재에 의한 농경지내 중금속 부하량에 근거하여 중금속 오염유무를 평가할 수 있는 판단기준에 대한 연구가 필요하다고 생각된다.

• 대한한방소아과학회지
• /
• 제23권3호
• /
• pp.9-36
• /
• 2009

Objectives The purpose of this study is to examine the effect of a concurrent administration of JUJSTK and AJ on atopic dermatitis in an in-vivo experiment. Thus, this study is expressed by using NC/Nga atopic dermatitis mice which have histological and clinical similarities to that of humans have been used. Methods Clinical skin score, hematology, serum total IgE and IgG1 of the mouse was evaluated, and cytokine levels, total number of the cells, immunohistochemical staining, histological features of axillary lymph node(ALN), peripheral blood mononuclear cells(PBMCs), and a dorsal skin tissue of the mouse were analyzed. Results Oral administration of JUJSTK and concurrent administration of JUJSTK and AJ lowered the clinical skin score, total cell number of WBC, eosinophils in blood, and serum total of IgE & IgG1, IFN-$\gamma$, IL-5, IL-13, IL-17. In addition, total cell number of ALN and dorsal skin tissue, absolute cell number of $CD3e^+$ T cell, $CD4^+$ Th cell, $CD8^+$ c/sT cell, $CD3^+CCR3^+$ cell, $CCR3^+$ cell, $CD3^+CD69^+$, $CD4^+CXCR5^+$ in ALN, PBMCs, absolute cell number of $CCR3^+$, $CD3^+/CD69^+$, $CD11b^+/Gr-1^+$, $CD11b^+/Gr-1^+$ in dorsal skin tissue, Eotaxin2 mRNA, CCR3 mRNA in dorsal skin tissue and gene expression of IL-5 mRNA, IL-13 mRNA in ALN were significantly decreased. Furthermore, thickness of epidermis infiltrated inflammatory immune cell & mast cell in dermis, histological infiltration of mast cell, the size of inflammatory lymphocytes cells & plasma cells in ALN and histological infiltration of $CD4^+$ & $CCR3^+$ in ALN and dorsal skin tissue were significantly decreased as well. Conclusions Concurrent administration of JUJSTK and AJ on atopic dermatitis in an in-vivoexperiment by using an NC/Nga atopic dermatitis mouse was very effective as an atopic dermatitis treatment.

• 동아시아식생활학회지
• /
• 제11권4호
• /
• pp.289-294
• /
• 2001

서해안에서 수집한 모시조개, 바지락. 맛조개. 꼬막, 소라 및 굴 등 6종의 조개류의 껍질수율과 외관, 껍질 및 열수 추출물의 무기질 및 중금속 함량을 조사하였다. 조개류 껍질의 비율은 70.1~80.5% 범위였으나 맛조개는 40.7%로 낮았다. 개체당의 껍질무게는 소라가 26.2 g으로 가장 높았고 맛조개가 5.6 g으로 가장 낮았다. 모시조개껍질은 노랑색을 띈 갈색, 바지락은 밝은 갈색. 맛조개와 꼬막은 검은색이었고 소라는 녹색을 띄는 갈색을, 굴은 어두운 회색을 띄었다. 조개류의 주 무기질은 Ca로 36.23~38.78%였으며, K는 0.23~4.54%, Na는 1.48~l.59%였다. 그외 Na, Mg, Fe, Mn, Zn, Cu, P, S 등은 0.0l~0.21% 범위로 함유되어 있었다. 중금속으로 Pb는 1.90~7.75 ppm, Cd는 0.5~4.50 ppm, As는 1.40~4.30 ppm, Se는 0.2~l.50 ppm Cr은 1.00~8.30 ppm, Hg는 0.002~8.2ppm이었다. 조개류 껍질로부터 물에 의하여 추출되는 Ca의 함량은 l15~2.448 mg/100g으로 맛조개가 가장 높았으며 바지락이 가장 낮았다. 물에 의하여 추출되는 K는 10~952 mg/100 g으로 모시조개가 가장 낮았고, 맛조개가 가장 높았다. 조개껍질의 무기질 추출율은 맛조개에서 전반적으로 높았으며 종류에 따라서 상당한 차이를 나타내었다. 특히. P는 맛조개가 201 mg/100 g으로 바지락 0.36 mg/100g에 비하여 현저히 높았다. Pb. As, Se 및 Cr의 물추출량은 맛조개에서 가장 높았으며 각각 110. 40, 90 및 20 $\mu$g/100 g이었다. 그러나 Cd는 바지락껍질에서만 검출되었다.

• 대한환경공학회지
• /
• 제33권2호
• /
• pp.93-102
• /
• 2011

본 연구에서는 부산신항만 준설퇴적물에 포함된 중금속의 총농도, 이동성, 생체이용률, 독성을 알아보기 위하여 총함량분석과 연속추출실험을 실시하였다. 준설퇴적물의 중금속 총농도는 다음과 같이 비교적 낮았다: Al (2.36~2.96 wt.%), As (1.6~3.3 mg/kg), Ba (30.0~33.8 mg/kg), Cd (0.12~0.18 mg/kg), Cr (27.5~35.0 mg/kg), Cu (11.3~15.0 mg/kg), Fe (2.91~3.51 wt.%), Mn (324~408 mg/kg), Ni (18.8~23.8 mg/kg), Pb (23.8~31.3 mg/kg), Zn (70.0~86.3 mg/kg). 또한 대부분의 중금속이 residual fraction으로 존재하였는데, 이는 오염원이 자연발생적일 가능성이 높음을 의미한다: Al (87.5~95.9%), As (74.1~93.8%), Ba (71.8~77.6%), Cr (69.5~94.3%), Cu (50.0~78.7%), Fe (70.8~87.6%), Ni (64.5~75.3%), Pb (53.4~64.3%), Zn (62.5~81.7%). 반면에 Cd과 Mn은 주로 non-residual fraction으로 존재했다. 준설퇴적물의 유해중금속 농도가 낮고 residual fraction 비율이 높기 때문에, 이를 벽돌, 도로포장재료 등으로 재활용하는 것이 가능하다고 사료된다.

• 한국식품과학회지
• /
• 제37권1호
• /
• pp.1-5
• /
• 2005

본 연구는 국내 유통되고 있는 두부류 총 175여건과 묵류 총 43건에 대하여 유도결합플라스마 분광기(ICP), 원자흡광광도계 (AAS), 수은분석기 등을 이용하여 납, 카드뮴 등 중금속 함량을 측정하였다 두부류 중 중금속의 최소치, 최대치 및 평균치는 수은 $0.1-8.2(0.3){\mu}g/kg$, 납 $ND-203.9(23.3){\mu}g/kg$, 카드뮴 $ND-46.0(8.1){\mu}g/kg$, 비소 $ND-61.3(0.7){\mu}g/kg$ 으로 나타났다. 또한 묵류중 중금속 함량은 수은 $0.1-1.3(0.3){\mu}g/kg$, 납 $ND-90.2(22.4){\mu}g/kg$, 카드뮴 $ND-31.0(3.7){\mu}g/kg$, 비소 $ND-23.6(1.1){\mu}g/kg$이었다, 본 연구결과, 우리나라 국민이 두부류 및 묵류를 통한 수은, 납, 카드뮴 섭취량은 FAO/WHO에서 설정한 잠정주 간섭취허용량의 각각 약 0.02% 0.3%, 0.3% 이하로 매우 낮은 수준이었다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권7호
• /
• pp.4421-4426
• /
• 2013

Objective: The present study employed 5-aza-2'-deoxycytidine (5-Aza-CdR) to treat non-small cell lung cancer (NSCLC) cell line A549 to investigate the effects on proliferation and expression of the TFPI-2 gene. Methods: Proliferation was assessed by MTT assay after A549 cells were treated with 0, 1, 5, 10 ${\mu}mol/L$ 5-Aza-CdR, a specific demethylating agent, for 24, 48 and 72h. At the last time point cells were also analyzed by flow cytometry (FCM) to identify any change in their cell cycle profiles. Methylation-specific polymerase chain reaction (MSPCR), real time polymerase chain reaction(real-time PCR) and western blotting were carried out to determine TFPI-2 gene methylation status, mRNA expression and protein expression. Results: MTT assay showed that the growth of A549 cells which were treated with 5-Aza-CdR was significantly suppressed as compared with the control group (0 ${\mu}mol/L$ 5-Aza-CdR). After treatment with 0, 1, 5, 10 ${\mu}mol/L$ 5-Aza-CdR for 72h, FCM showed their proportion in G0/G1 was $69.7{\pm}0.99%$, $76.1{\pm}0.83%$, $83.8{\pm}0.35%$, $95.5{\pm}0.55%$ respectively (P<0.05), and the proportion in S was $29.8{\pm}0.43%$, $23.7{\pm}0.96%$, $15.7{\pm}0.75%$, $1.73{\pm}0.45%$, respectively (P<0.05), suggesting 5-Aza-CdR treatment induced G0/G1 phase arrest. MSPCR showed that hypermethylation in the promoter region of TFPI-2 gene was detected in control group (0 ${\mu}mol/L$ 5-Aza-CdR), and demethylation appeared after treatment with 1, 5, 10 ${\mu}mol/L$ 5-Aza-CdR for 72h. Real-time PCR showed that the expression levels of TFPI-2 gene mRNA were $1{\pm}0$, $1.49{\pm}0.14$, $1.86{\pm}0.09$ and $5.80{\pm}0.15$ (P<0.05) respectively. Western blotting analysis showed the relative expression levels of TFPI-2 protein were $0.12{\pm}0.01$, $0.23{\pm}0.02$, $0.31{\pm}0.02$, $0.62{\pm}0.03$ (P<0.05). TFPI-2 protein expression in A549 cells was gradually increased significantly with increase in the 5-Aza-CdR concentration. Conclusions: TFPI-2 gene promoter methylation results in the loss of TFPI-2 mRNA and protein expression in the non-small cell lung cancer cell line A549, and 5-Aza-CdR treatment could induce the demethylation of TFPI-2 gene promoter and restore TFPI-2 gene expression. These findings provide theoretic evidence for clinical treatment of advanced non-small cell lung cancer with the demethylation agent 5-Aza-CdR. TFPI-2 may be one molecular marker for effective treatment of advanced non-small cell lung cancer with 5-Aza-CdR.

• 환경위생공학
• /
• 제14권3호
• /
• pp.63-70
• /
• 1999

A study on the zeolite synthesized of bituminous coal fly ash from power plant has been carried out to reuse industrial waste. The synthesized zeolite was proved to be 4A type by means of the X-ray diffraction analysis and the degree of crystallinity was found to be higher than 90%. Then the synthesized zeolite was used as an adsorbent to remove the heavy metal ions in the CU, Pb, and Cd containing wastewater and water. Also, adsorption characteristics and kinetics of synthesized zeolite in the each metal ion solutions were studied. In each ion solutions, the adsorbed amounts of Pb, Cd, and Cu to the unit weight of synthesized zeolite were 141.6, 118.8, and 131.4mg/g respectively when each metal ion concentration was 500mg/L solution. The adsorption kinetics was fitted well to the Freundlich isotherms. The value of l/n for Pb, Cd, and Cu and 0.27, 0.50, and 0.66, respectively. Those results showed that the synthesized zeolite could be used as an adsorbent to remove single heavy metal ions in the wastewater and water. The heats of adsorption, H values of Pb, Cd, and Cu were 4.87, 14.95, and 18.23kacl/mol by the Henry-van't Hoff equation.

• 대한한방소아과학회지
• /
• 제23권2호
• /
• pp.87-101
• /
• 2009

Objectives : The purpose of this study is to investigate the effect of JUJSTK on atopic dermatitis in an in-vitro experiment using an NC/Nga atopic dermatitis mouse, which has histological and clinical similarities to the humans in terms of health condition. Methods : We evaluated IL-1$\beta$, IL-6, IL-10, TNF-$\alpha$ mRNA, TGF-$\beta$ mRNA, CD4+/IFN-$\gamma$+ and IL-17+CD4+Th17 cells of NC/Nga atopic dermatitis mouse by real-time PCR and intracellular staining in vitro. Results : JUJSTK medicines supressed the activities of IL-1$\beta$, IL-6, TNF-$\alpha$, TGF-$\beta$ mRNA and IL-17+CD4+Th17 cells and it incresed the activities of IL-10 mRNA in B cells. The level of CD4+/IFN-$\gamma$+ in T cells were increased by JUSSTK. Conclusions : JUJSTK on atopic dermatitis might be incredibly effective to the atopic dermatitis treatment.

• Biomolecules & Therapeutics
• /
• 제23권6호
• /
• pp.493-509
• /
• 2015

Antibody-drug conjugates utilize the antibody as a delivery vehicle for highly potent cytotoxic molecules with specificity for tumor-associated antigens for cancer therapy. Critical parameters that govern successful antibody-drug conjugate development for clinical use include the selection of the tumor target antigen, the antibody against the target, the cytotoxic molecule, the linker bridging the cytotoxic molecule and the antibody, and the conjugation chemistry used for the attachment of the cytotoxic molecule to the antibody. Advancements in these core antibody-drug conjugate technology are reflected by recent approval of Adectris$^{(R)}$(anti-CD30-drug conjugate) and Kadcyla$^{(R)}$(anti-HER2 drug conjugate). The potential approval of an anti-CD22 conjugate and promising new clinical data for anti-CD19 and anti-CD33 conjugates are additional advancements. Enrichment of antibody-drug conjugates with newly developed potent cytotoxic molecules and linkers are also in the pipeline for various tumor targets. However, the complexity of antibody-drug conjugate components, conjugation methods, and off-target toxicities still pose challenges for the strategic design of antibody-drug conjugates to achieve their fullest therapeutic potential. This review will discuss the emergence of clinical antibody-drug conjugates, current trends in optimization strategies, and recent study results for antibody-drug conjugates that have incorporated the latest optimization strategies. Future challenges and perspectives toward making antibody-drug conjugates more amendable for broader disease indications are also discussed.